...
首页> 外文期刊>Leukemia and lymphoma >Myelodysplastic syndrome macrophages have aberrant iron storage and heme oxygenase-1 expression
【24h】

Myelodysplastic syndrome macrophages have aberrant iron storage and heme oxygenase-1 expression

机译:骨髓增生异常综合征巨噬细胞具有异常的铁存储和血红素加氧酶-1表达

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Iron overload and transfusion dependance portend poor risk in myelodysplastic syndromes (MDS); bone marrow macrophages store iron and limit oxidative damage through heme oxygenase-1 (HO1). We assessed iron stores and macrophage HO1 expression in MDS using image analysis of intact diagnostic bone marrow biopsies and qualitative scoring of marrow aspirate iron among 129 cytopenic patients, 67 with MDS and 62 similarly aged patients with benign cytopenias. Using double immunofluorescence and sequential iron and immunohistochemistry staining, we showed that marrow iron colocalizes with HO1 and H-ferritin to CD163+macrophages. Marrow iron was elevated in MDS independent of transfusion status, a finding of potential utility in distinguishing benign cytopenia from MDS. Among MDS patients only, CD163+macrophage density and HO1 and H-ferritin expression by CD163+macrophages increased in tandem with marrow iron. High HO1 was significantly associated with shorter overall survival among MDS patients independent of IPSSR and history of transfusion.
机译:铁超载和输血依赖预示着骨髓增生异常综合症(MDS)的风险较低;骨髓巨噬细胞储存铁并通过血红素加氧酶-1(HO1)限制氧化损伤。我们使用完整的诊断性骨髓活检的图像分析以及129例血细胞减少症患者,67例MDS患者和62例年龄相似的良性血细胞减少症患者的骨髓穿刺铁的定性评分,评估了MDS中的铁存储和巨噬细胞HO1表达。使用双重免疫荧光和连续铁以及免疫组织化学染色,我们显示骨髓铁与HO1和H-铁蛋白共定位于CD163 +巨噬细胞。 MDS中的骨髓铁水平升高,与输血状态无关,这是区分良性血细胞减少症和MDS的潜在用途。仅在MDS患者中,CD163 +巨噬细胞密度和CD163 +巨噬细胞的HO1和H-铁蛋白表达与骨髓铁一起增加。高HO1与独立于IPSSR和输血史的MDS患者的总体生存期缩短显着相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号